According to the FDA s draft guidance, PDURS provides a practical pathway to add a companion software to the label to promote patient outcomes and safety
He talked to medical director Evan Blum, MD, who prescribed Turner a regimen of 0.2 milligrams of semaglutide, the active ingredient in the GLP-1 meds Wegovy and Ozempic, taken every seven days
Potential risks include breast tenderness, headaches, slight increase in breast cancer risk with prolonged synthetic progestin use (not seen with micronized progesterone), blood clot risk with oral estrogen (not transdermal), and gallbladder disease risk with oral estrogen
Weight can be frustrating when the same pattern keeps repeating: progress for a few weeks, then cravings, low energy, a plateau, or weight gain after a busy season